Join Dr Sian Morgan to discover QuicDNA MAX and the future of precision oncology in the NHS.

TOPICS COVERED

Online lecture: The QuicDNA Max Programme builds on the experience, infrastructure, and clinical success of the initial QuicDNA study, evolving into an ambitious research programme aimed at embedding precision oncology into routine NHS care. This next phase significantly expands the scope of liquid biopsy genomic profiling by encompassing a broader spectrum of tumour types. The programme supports personalised treatment access by integrating circulating tumour DNA (ctDNA) testing into standard cancer diagnostic and treatment pathways.
QuicDNA Max aims to mainstream cancer genomics, understand clinical needs, and collaboratively support and enhance the cancer workforce, in alignment with the ambitions of the Welsh Government Tackling Cancer Initiative, Welsh Genomics Implementation Plan, Advanced Therapies in Wales Delivery Plan, and National Diagnostic Strategy, and NHS Wales’ broader vision to lead in clinical trial integration, digital and data transformation, and off-license therapy access (such as the Determine trial). The programme serves as a dynamic platform for collaboration between industry, academia, and the NHS, embedding cutting-edge genomic technologies and evidence-based practices into routine clinical care.
By delivering high-quality, evidence-based genomic testing services across NHS Wales, QuicDNA Max is aligned also with the pace and ambition of the other UK nations.

WHO SHOULD ATTEND?

Ideal for clinicians, clinical scientists, and researchers interested in precision oncology and genomic testing in the NHS.

SPEAKER

Sian Morgan BSc, MPhil, DipACC, FRCPath is a Consultant Clinical Scientist at All Wales Medical Genomics Service (AWMGS) and a Honorary Senior Research Fellow - Cardiff University.

For more information, please contact: [email protected].